Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I data on SLN-124 support ongoing evaluation in patients with thalassemia and MDS

May 19, 2021

Veru advances VERU-111 into phase III for treatment of COVID-19

May 19, 2021

CoVac-1, a COVID-19 vaccine useful for cancer patients undergoing B-cell depleting therapy

May 19, 2021

NADI-351 shows significant antitumor activity and low toxicity in xenograft models

May 19, 2021

Applied Genetic Technologies patents new AAV vectors

May 19, 2021

Eccogene (Shanghai) identifies SSAO inhibitors

May 19, 2021

Inhibition of CAMK1D restores sensitivity in PD-L1 refractory tumors

May 19, 2021

Amgen synthesizes GTPase KRAS mutant inhibitors

May 19, 2021

Medshine Discovery discloses xanthine oxidase inhibitors

May 19, 2021

Anti-BAFF therapy eradicates factor VIII inhibitors in hemophilia A

May 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...